NEXENTIS TECHNOLOGIES INC. Long-term Line of Credit
NEXENTIS TECHNOLOGIES INC. (NXTS) had Long-term Line of Credit of EUR 181.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified
us-gaap:LineOfCredit · last filed 2026-08-13
- 2026-06-30: Long-term Line of Credit 181.00K EUR.
- 2026-03-31: Long-term Line of Credit 89.00K EUR.
- 2025-12-31: Long-term Line of Credit 202.00K EUR.
- 2025-06-30: Long-term Line of Credit 593.00K EUR.
EUR
| Period end | Long-term Line of Credit |
|---|---|
| 2026-06-30 | 181.00K EUR 10-Q · filed 2026-08-13 |
| 2026-03-31 | 89.00K EUR 10-Q · filed 2026-05-14 |
| 2025-12-31 | 202.00K EUR 10-K · filed 2026-03-31 |
| 2025-06-30 | 593.00K EUR 10-Q · filed 2025-08-14 |
| 2025-03-31 | 704.00K EUR 10-Q · filed 2025-05-15 |
USD
| Period end | Long-term Line of Credit |
|---|---|
| 2026-06-30 | $207.00K 10-Q · filed 2026-08-13 |
| 2026-03-31 | $103.00K 10-Q · filed 2026-05-14 |
| 2025-12-31 | $237.00K 10-Q · filed 2026-08-13 |
| 2025-09-30 | $10.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $699.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $764.00K 10-Q · filed 2025-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |